Skip to content
Showing 1 - 10 of 34 results.
Labs across the globe have mobilized in historic fashion to try to find a treatment for COVID-19. Scott Pelley reports on which therapeutics are causing optimism.
Labs around the world are racing to develop therapeutic drugs to reduce the severity of the disease. We're going to share with you some of the most promising leads for treating COVID-19, today.
Now working on monoclonal antibodies to treat COVID-19, the virologist gained recognition in the 1990s for treating Magic Johnson. He first appeared on 60 Minutes in 1998.
The infusion of a monoclonal antibody cocktail to treat the virus that causes COVID represents a true advance in both treatment and prevention of SARS-CoV-2 infection.
Dr. David Ho, scientific director and CEO of the Aaron Diamond AIDS Research Center, talks about Regeneron, the experimental antibody cocktail that Donald Trump was given as treatment for Covid-19.
There is now a worldwide race to develop, manufacture and buy Covid-19 vaccines even before any of them have proved to be effective. Dr. David Ho is interviewed by Ms. Yvonne Tong from RTHK.
Adimmune begins phase I trial of COVID-19 vaccine in October and phase II trial in December 2020.
The United States is now looked upon by countries in Europe with incredulity and alarm as the pandemic continues rage with the US leading the world in cases and deaths.
Regeneron, Eli Lily, and Astra Zeneca are among a number of major pharmaceutical companies testing neutralizing antibody cocktails to treat and prevent SARS-CoV-2 infection.
Dr. David Ho joins Meg Tirrell on CNBC’s “Healthy Returns: The Path Forward”. He discusses the SARS-CoV-2 pandemic and the work of his research team at the Aaron Diamond Aids Research Center.